ICPT logo

ICPT Return On Equity

Annual ROE

238.31%
+188.61%+379.50%

December 31, 2022


Summary


Performance

ICPT ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherICPTprofitabilitymetrics:

Quarterly ROE

-75.63%
-324.38%-130.40%

September 30, 2023


Summary


Performance

ICPT Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherICPTprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

ICPT ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+379.5%+25.1%
3 y3 years+124.4%-111.3%
5 y5 years+209.6%+85.5%

ICPT ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-79.1%-130.4%+974.3%
5 y5-yearat high-509.2%-111.3%+974.3%
alltimeall time-52.1%-830.7%-111.3%+1262.7%

Intercept Pharmaceuticals ROE History

DateAnnualQuarterly
Sep 2023
-
-75.63%(-130.4%)
Jun 2023
-
248.75%(-130.6%)
Mar 2023
-
-812.46%(+395.3%)
Dec 2022
238.31%(+379.5%)
-164.05%(+62.6%)
Sep 2022
-
-100.92%(-521.6%)
Jun 2022
-
23.94%(-19.8%)
Mar 2022
-
29.86%(-39.3%)
Dec 2021
49.70%(-69.8%)
49.21%(-16.7%)
Sep 2021
-
59.11%(-39.2%)
Jun 2021
-
97.17%(-37.1%)
Mar 2021
-
154.40%(-42.3%)
Dec 2020
164.74%(-116.9%)
267.75%(-59.9%)
Sep 2020
-
667.67%(-196.0%)
Jun 2020
-
-695.25%(+7.2%)
Mar 2020
-
-648.67%(+21.1%)
Dec 2019
-975.25%(-44.0%)
-535.85%(+17.2%)
Sep 2019
-
-457.16%(+11.1%)
Jun 2019
-
-411.49%(-60.1%)
Mar 2019
-
-1030.61%(+50.4%)
Dec 2018
-1741.42%(+700.5%)
-685.30%(+31.1%)
Sep 2018
-
-522.55%(+20.3%)
Jun 2018
-
-434.45%(+19.9%)
Mar 2018
-
-362.38%(+71.5%)
Dec 2017
-217.54%
-211.25%(+43.2%)
DateAnnualQuarterly
Sep 2017
-
-147.48%(+19.1%)
Jun 2017
-
-123.79%(+23.4%)
Mar 2017
-
-100.28%(+8.7%)
Dec 2016
-90.03%(+65.6%)
-92.27%(+25.9%)
Sep 2016
-
-73.28%(+24.2%)
Jun 2016
-
-59.00%(+8.6%)
Mar 2016
-
-54.33%(+26.2%)
Dec 2015
-54.36%(-69.9%)
-43.05%(+13.9%)
Sep 2015
-
-37.79%(-9.0%)
Jun 2015
-
-41.55%(+11.1%)
Mar 2015
-
-37.39%(-81.2%)
Dec 2014
-180.80%(+97.8%)
-199.30%(-12.8%)
Sep 2014
-
-228.49%(-24.2%)
Jun 2014
-
-301.36%(-61.0%)
Mar 2014
-
-771.77%(+848.0%)
Dec 2013
-91.41%(-33.7%)
-81.41%(-33.9%)
Sep 2013
-
-123.18%(+15.2%)
Jun 2013
-
-106.91%(-33.3%)
Mar 2013
-
-160.20%(-9.2%)
Dec 2012
-137.84%(-127.7%)
-176.49%(+17.0%)
Sep 2012
-
-150.88%(-7.7%)
Jun 2012
-
-163.47%(-145.7%)
Mar 2012
-
358.09%(+41.3%)
Dec 2011
497.61%
253.41%

FAQ

  • What is Intercept Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual ROE year-on-year change?
  • What is Intercept Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly ROE year-on-year change?

What is Intercept Pharmaceuticals annual return on equity?

The current annual ROE of ICPT is 238.31%

What is the all time high annual ROE for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual return on equity is 497.61%

What is Intercept Pharmaceuticals annual ROE year-on-year change?

Over the past year, ICPT annual return on equity has changed by +188.61% (+379.50%)

What is Intercept Pharmaceuticals quarterly return on equity?

The current quarterly ROE of ICPT is -75.63%

What is the all time high quarterly ROE for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly return on equity is 667.67%

What is Intercept Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, ICPT quarterly return on equity has changed by +25.29% (+25.06%)